Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease

NCT06819410 · tracked via the Priya Life Science China tracker

Sponsor

Sichuan Provincial People's Hospital

Phase

Observational

Started

2021-05-01

Last updated

2025-02-11

Condition(s) studied

Invasive Fungal Disease

Study summary

Efficacy and safety of amphotericin B and azoles in the treatment of invasive fungal disease

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * There is no age limit, gender is not limited * Patients with invasive fungal disease who are treated with polyene antifungals or azole antifungals should be treated for ≥ 7 days. Exclusion Criteria: * Patients with incomplete data or other factors affecting the clinical outcome judgement * Patients who are judged by the investigator to be unsuitable to participate in this study.

Primary outcome measure(s)

Clinical success rate — The end of treatment, up to 1 year
Clinical success incudes cure or symptom improvement，which means patients are alive, IFD-related symptoms and signs, radiographic abnormalities improve or disappear completely, and microbiological evidence suggests fungal clearance. The proportion of patients with cured or improved symptoms in the total population was analyzed.

Trial sites (1)

Facility	City	Region	Status
Sichuan Provincial People's Hospital	Chengdu	Sichuan	Recruiting

More Sichuan Provincial People's Hospital trials in China

[18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease Recruiting

Safety and Efficacy of Connecting the Residual Ear to the Cartilage Scaffold in First- vs. Second-Stage Surgery Starting soon

Mechanism of Red Yeast Rice Regulating Intestinal Indole Metabolism Pathway to Improve Chronic Inflammation in Polycystic Ovary Syndrome Recruiting

Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds Starting soon

A Single-center Study of CM313 in Patients With Pemphigus Starting soon

Other trials for the same condition

Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation Recruiting

Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients Starting soon

Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological Diseases Recruiting

mNGS for IFD in Patients With Hematological Malignancies Starting soon

Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06819410 on ClinicalTrials.gov ↗ ← All trials in China